Richard Bungay Buys 8,000 Shares of Diurnal Group PLC (LON:DNL) Stock

Share on StockTwits

Diurnal Group PLC (LON:DNL) insider Richard Bungay purchased 8,000 shares of the business’s stock in a transaction that occurred on Monday, June 24th. The stock was bought at an average cost of GBX 30 ($0.39) per share, for a total transaction of £2,400 ($3,136.03).

Shares of LON DNL opened at GBX 29.50 ($0.39) on Wednesday. The company has a market cap of $24.94 million and a P/E ratio of -1.08. Diurnal Group PLC has a 12-month low of GBX 21 ($0.27) and a 12-month high of GBX 194 ($2.53). The business has a 50 day moving average of GBX 29.84.

Diurnal Group Company Profile

Diurnal Group plc operates as a specialty pharma company. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients, as well as adrenal insufficiency.

Further Reading: Book Value Per Share – BVPS

Receive News & Ratings for Diurnal Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diurnal Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Expect Agilent Technologies Inc  Will Announce Earnings of $0.72 Per Share
Analysts Expect Agilent Technologies Inc Will Announce Earnings of $0.72 Per Share
FOAM Trading Down 2.1% Over Last Week
FOAM Trading Down 2.1% Over Last Week
Footy Cash   Trading 5.8% Lower  Over Last Week
Footy Cash Trading 5.8% Lower Over Last Week
Aspen Group  vs. Sunlands Online Education Group  Critical Survey
Aspen Group vs. Sunlands Online Education Group Critical Survey
Electroneum  Trading 2.7% Higher  Over Last 7 Days
Electroneum Trading 2.7% Higher Over Last 7 Days
JPMorgan Chase & Co. Lowers News  to Underweight
JPMorgan Chase & Co. Lowers News to Underweight


 
© 2006-2019 Zolmax.